Secura   Report issue

For profit Phase 1 Phase 2
Founded: Las Vegas NV United States (2019)
Status: No NME R&D (2019)

Organization Overview

First Clinical Trial
2019
NCT04897880
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

SECURA | SecuraBio | Secura Bio | Secura Bio, Inc.